SUMMARY The biochemical and physiological defects underlying human dysmorphic syndromes can now be approached using techniques of molecular biology. The genetic component of the causation of the dysmorphology can be studied in isolation from the environmental component by using large, rare families which exhibit the same phenotype as more complex multifactorial disorders, but inherit the mutation in a monogenic fashion. Such an analysis starts with the determination of linkage to a gene probe, followed by the use of newer techniques of molecular biology to enable cloning and sequencing of the mutated gene.
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Analysis of the gene product by amino acid sequence homology to other known proteins, and tissue specific expression, may place the defect within the cascade of events associated with development and differentiation. Once cloned, the gene can also be manipulated in transgenic laboratory animals and the effect of its mutation studied directly. The use of techniques of molecular biology to study the genetic aspects of dysmorphic syndromes will allow insight to be gained both into normal fetal development and into the causes of congenital malformations.
The human genome has approximately 109 base pairs of DNA in 22 pairs of autosomes and the sex chromosomes. In addition to the several tens of thousands of genes which code for proteins, this complex of information also contains the instructions required for differentiation and development. It is only with the advent of recombinant DNA technology that we have been able to study the structure and function of the genes that control these processes at the molecular level. As a result of random mutations in the human genome, changes in the pattern of cleavage of restriction enzymes occur, which provide specific polymorphic markers, inherited in a Mendelian manner. The analysis of the patterns of inheritance of these markers in family studies provides a tool with which to map any gene and to study its cosegregation with any normal or abnormal variant phenotype.
It is now just over 10 years since the first mammalian gene, rabbit globin, was cloned. Since then, the advance in molecular genetics has been even greater than predicted by the most optimistic, with over 3500 markers identified. A necessary prerequisite for the study of a disease at the DNA level is a genetic model; a small proportion of dysmorphic syndromes appear to be simply monogenic or polygenic, with no environmental component. However, most fall into the category of multifactorial disorders, determined by the varying contribution of both intrinsic and extrinsic factors, such that any given case will be the result of the net effect of these factors, as in coronary heart disease.4 It is important to distinguish between multifactorial and polygenic inheritance; we use the latter term in a restricted sense with reference to conditions caused exclusively by a large number of genes and with minimal extrinsic involvement. We also note that conditions which are multifactorial in general may nonetheless be monogenic or polygenic in a given family, as will be seen for one large family with cleft palate that we have studied. 473
The role that chance plays in the occurrence of malformations has recently been studied in the form of a stochastic single gene model. One initial approach to the understanding of the molecular basis of a dysmorphology lies in the identification of pedigrees in which a simple disease phenotype manifests as a purely genetic entity, but exhibits all the features of the more common polygenic or multifactorial disorder. These 'model families' do exist for many disorders both in humans and in the mouse. This review is concerned with the technology available to identify and analyse a defective gene, some of the clues to candidate developmental genes, and future perspectives of molecular biology with respect to correction of the defect involved.
Techniques of gene analysis
Since the introduction of gene cloning 10 years ago, one of the goals of molecular biologists has been to understand the mechanisms that cause a single diploid cell to develop and differentiate into a human being. The application of both molecular and genetic analysis has brought us a great distance towards understanding the genetics which underlies both the structure and function of organisms such as E coli and Drosophila melanogaster. These techniques have been difficult to apply to mammals, however, primarily owing to the sheer size of the mammalian genome.
If a genetic marker which has been mapped to a particular chromosome is always associated with a disease, then the disease may be assumed to be on that chromosome. In studying linkage, one very considerable contribution of molecular biology has been the observation that, even more than proteins, DNA sequences show abundant polymorphism. ' 32 In all instances studied, the homeo box is part of an open reading frame and the sequence has been detected in mRNA. A comparison of a number of homeo box genes indicated a helix-turnhelix DNA binding motif within the box domain33; it is thought that the activity of these genes is mediated by direct binding to controlling/promoting sequences of important genes.
Using the Drosophila homeo box sequence as probes, it has been possible to identify homologous sequences in a wide variety of vertebrates, including man. Interestingly, the mammalian sequences show high degrees of homology to the Drosophila probe, typically 70 to 95%. In addition to their strong primary sequence homology, there are other common features. The majority of homeo box copies in both Drosophila and mammalian genomes are organised within physically linked clusters. At least three human homeo boxes are known to be localised in a 20 000 base pair stretch of DNA.34 A similar situation is found in the mouse.35 36 Even more striking is the similarity between homeo box containing genes in mouse and man, which are more homologous to each other (>90%) than to the Drosophila sequences.36
The two main mouse homeotic clusters, Hox-1 and Hox-2, have been localised to chromosomes 6 and 11, and contain six and at least four homeo boxes respectively.37 In all cases, these murine sequences were shown to be parts of genes whose patterns of expression are specific for given stages of embryogenesis, or for restricted numbers of adult tissues or cell lineages. 3 37 It appears that some are coordinately regulated, being expressed in the same embryonic structure but at different times.3842
Similarly, if homeo box genes direct specific morphogenetic functions during development, as for Drosophila, one could predict specific spatial expression. This is elegantly shown for the murine Hox-3 and the human HHO.c1O, with expression limited to the central nervous system.38 39 The homeo boxes found in several Drosophila genes control segmentation: do they have the same function in mammals? It Integration of the cloned gene into the host genome appears to be random, but the gene does remain in both germline and somatic cells. Unfortunately, by virtue of the experiment itself, we are selecting for integration events that are compatible with normal embryonic development, those that do not involve important morphogenic genes, or those that remain silent or underexpressed.
An exciting development using fused genes, in which the 5' regulatory sequences of the mouse metallothionine gene were attached to the coding sequences of the rat growth hormone gene, indicated the power of transgenic analysis. In this case, the gene was induced by heavy metals and resulted in growth hormone levels 100 to 800 times that of the controls, with concomitant rapid growth of the mice.
Other examples of important transgenic experiments include (1) the construction of a mouse model for Lesch-Nyhan syndrome by introduction of a mutant HPRT into mice using transgenic embryonal stem (ES) cell lines56 57; (2) cell lineage ablation in transgenic mice by cell specific expression of a toxin gene58; and (3) the correction of dysmyelinating phenotype by the introduction of the wild type gene into shiverer mice by microinjection; correct temporal and spatial expression of the gene was achieved.59 This raises the possibility of gene therapy in man and its prospects will, in the future, be the subject of continued debate. ') However, from the point of view of this review, it is more interesting to note that there are now many models of single genes which, when introduced into cells or organisms, alter morphology in a complex yet defined fashion. The experimental imperatives are to gain precision in site of integration and to improve expression, which will enable us to study many genes important in defining morphology during embryogenesis and differentiation.
